See today's BioWorld
To read the full story, subscribe or sign in.

AVI Starting Avicine Phase III To Speed Approval Timeline

May 3, 2002
By Karen Young
AVI BioPharma Inc. changed the course for its lead anticancer product, the vaccine Avicine, in an effort to shorten the route toward a possible FDA approval. (BioWorld Today)
BioWorld